Search results
Results from the WOW.Com Content Network
Nebivolol is a beta blocker used to treat high blood pressure and heart failure. [5] As with other β-blockers, it is generally a less preferred treatment for high blood pressure. [6] It may be used by itself or with other blood pressure medication. [6] It is taken by mouth. [6] Common side effects include dizziness, feeling tired, nausea, and ...
For patients with more than 1,000 PVCs per day, the risk of developing left ventricular systolic dysfunction after 5 years follow-up is low. Frequent PVCs may increase the risk of developing cardiomyopathy, which can greatly impair heart function. A PVC burden greater than 10% is the minimal threshold for development of PVC-induced cardiomyopathy.
Beta-blockers. Calcium-channel blockers. Disopyramide. Dilated cardiomyopathy is one of the main causes of heart failure. It occurs in about 1 in 2,500 people. Treatment for dilated cardiomyopathy ...
Bisoprolol, sold under the brand name Zebeta among others, is a beta blocker which is selective for the beta-1 receptor [7] and used for cardiovascular diseases, [7] including tachyarrhythmias, high blood pressure, angina, and heart failure.
Sotalol is a beta blocker and non-selectively binds to both β 1-and β 2-adrenergic receptors preventing activation of the receptors by their stimulatory ligand (catecholamines). [11] [12] It has no intrinsic sympathomimetic activity. [12]
Therefore, blocking β 2-adrenoceptors lowers plasma glucose. β 1-blockers have fewer metabolic side effects in diabetic patients; however, the fast heart rate that serves as a warning sign for insulin-induced low blood sugar may be masked, resulting in hypoglycemia unawareness. This is termed beta blocker-induced hypoglycemia unawareness ...
Nadolol is a non-selective beta blocker; that is, it non-selectively blocks both beta-1 and beta-2 receptors. It has a preference for beta-1 receptors, which are predominantly located in the heart, thereby inhibiting the effects of catecholamines and causing a decrease in heart rate and blood pressure.
ICI-118,551 is a selective β 2 adrenergic receptor (adrenoreceptor) antagonist or beta blocker. [1] [2] ICI binds to the β 2 subtype with at least 100 times greater affinity than β 1 or β 3, the two other known subtypes of the beta adrenoceptor. [3] [4] The compound was developed by Imperial Chemical Industries, which was acquired by ...